C A Lane, J Hardy, J M Schott. Eur J Neurol 2018
Times Cited: 784
Times Cited: 784
Times Cited
Times Co-cited
Similarity
The amyloid hypothesis of Alzheimer's disease at 25 years.
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
Dennis J Selkoe, John Hardy. EMBO Mol Med 2016
11
Oxidative stress and the amyloid beta peptide in Alzheimer's disease.
C Cheignon, M Tomas, D Bonnefont-Rousselot, P Faller, C Hureau, F Collin. Redox Biol 2018
C Cheignon, M Tomas, D Bonnefont-Rousselot, P Faller, C Hureau, F Collin. Redox Biol 2018
7
Alzheimer's disease.
Jose A Soria Lopez, Hector M González, Gabriel C Léger. Handb Clin Neurol 2019
Jose A Soria Lopez, Hector M González, Gabriel C Léger. Handb Clin Neurol 2019
7
The neuropathological diagnosis of Alzheimer's disease.
Michael A DeTure, Dennis W Dickson. Mol Neurodegener 2019
Michael A DeTure, Dennis W Dickson. Mol Neurodegener 2019
7
Alzheimer's disease.
Philip Scheltens, Kaj Blennow, Monique M B Breteler, Bart de Strooper, Giovanni B Frisoni, Stephen Salloway, Wiesje Maria Van der Flier. Lancet 2016
Philip Scheltens, Kaj Blennow, Monique M B Breteler, Bart de Strooper, Giovanni B Frisoni, Stephen Salloway, Wiesje Maria Van der Flier. Lancet 2016
6
Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
Valeria Calsolaro, Paul Edison. Alzheimers Dement 2016
Valeria Calsolaro, Paul Edison. Alzheimers Dement 2016
6
Current understanding of Alzheimer's disease diagnosis and treatment.
Jason Weller, Andrew Budson. F1000Res 2018
Jason Weller, Andrew Budson. F1000Res 2018
6
Drug treatments in Alzheimer's disease.
Robert Briggs, Sean P Kennelly, Desmond O'Neill. Clin Med (Lond) 2016
Robert Briggs, Sean P Kennelly, Desmond O'Neill. Clin Med (Lond) 2016
6
Neuropathological stageing of Alzheimer-related changes.
H Braak, E Braak. Acta Neuropathol 1991
H Braak, E Braak. Acta Neuropathol 1991
6
Neuropathological alterations in Alzheimer disease.
Alberto Serrano-Pozo, Matthew P Frosch, Eliezer Masliah, Bradley T Hyman. Cold Spring Harb Perspect Med 2011
Alberto Serrano-Pozo, Matthew P Frosch, Eliezer Masliah, Bradley T Hyman. Cold Spring Harb Perspect Med 2011
6
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.
Justin M Long, David M Holtzman. Cell 2019
Justin M Long, David M Holtzman. Cell 2019
6
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.
J C Lambert, C A Ibrahim-Verbaas, D Harold, A C Naj, R Sims, C Bellenguez, A L DeStafano, J C Bis, G W Beecham, B Grenier-Boley,[...]. Nat Genet 2013
J C Lambert, C A Ibrahim-Verbaas, D Harold, A C Naj, R Sims, C Bellenguez, A L DeStafano, J C Bis, G W Beecham, B Grenier-Boley,[...]. Nat Genet 2013
5
Alzheimer's disease: pathogenesis, diagnostics, and therapeutics.
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, Adriana Yndart, Madhavan Nair. Int J Nanomedicine 2019
Sneham Tiwari, Venkata Atluri, Ajeet Kaushik, Adriana Yndart, Madhavan Nair. Int J Nanomedicine 2019
5
Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease.
Fuyuki Kametani, Masato Hasegawa. Front Neurosci 2018
Fuyuki Kametani, Masato Hasegawa. Front Neurosci 2018
5
Amyloid toxicity in Alzheimer's disease.
Allison B Reiss, Hirra A Arain, Mark M Stecker, Nicolle M Siegart, Lora J Kasselman. Rev Neurosci 2018
Allison B Reiss, Hirra A Arain, Mark M Stecker, Nicolle M Siegart, Lora J Kasselman. Rev Neurosci 2018
5
Alzheimer's disease.
Clive Ballard, Serge Gauthier, Anne Corbett, Carol Brayne, Dag Aarsland, Emma Jones. Lancet 2011
Clive Ballard, Serge Gauthier, Anne Corbett, Carol Brayne, Dag Aarsland, Emma Jones. Lancet 2011
5
Neuroinflammation in Alzheimer's disease.
Michael T Heneka, Monica J Carson, Joseph El Khoury, Gary E Landreth, Frederic Brosseron, Douglas L Feinstein, Andreas H Jacobs, Tony Wyss-Coray, Javier Vitorica, Richard M Ransohoff,[...]. Lancet Neurol 2015
Michael T Heneka, Monica J Carson, Joseph El Khoury, Gary E Landreth, Frederic Brosseron, Douglas L Feinstein, Andreas H Jacobs, Tony Wyss-Coray, Javier Vitorica, Richard M Ransohoff,[...]. Lancet Neurol 2015
5
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
5
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.
Berislav V Zlokovic. Nat Rev Neurosci 2011
Berislav V Zlokovic. Nat Rev Neurosci 2011
5
4
Amyloid precursor protein processing and Alzheimer's disease.
Richard J O'Brien, Philip C Wong. Annu Rev Neurosci 2011
Richard J O'Brien, Philip C Wong. Annu Rev Neurosci 2011
4
Inflammation and Alzheimer's disease.
H Akiyama, S Barger, S Barnum, B Bradt, J Bauer, G M Cole, N R Cooper, P Eikelenboom, M Emmerling, B L Fiebich,[...]. Neurobiol Aging 2000
H Akiyama, S Barger, S Barnum, B Bradt, J Bauer, G M Cole, N R Cooper, P Eikelenboom, M Emmerling, B L Fiebich,[...]. Neurobiol Aging 2000
4
Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy.
Marc Fakhoury. Curr Neuropharmacol 2018
Marc Fakhoury. Curr Neuropharmacol 2018
4
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Stephen Salloway, Reisa Sperling, Nick C Fox, Kaj Blennow, William Klunk, Murray Raskind, Marwan Sabbagh, Lawrence S Honig, Anton P Porsteinsson, Steven Ferris,[...]. N Engl J Med 2014
Stephen Salloway, Reisa Sperling, Nick C Fox, Kaj Blennow, William Klunk, Murray Raskind, Marwan Sabbagh, Lawrence S Honig, Anton P Porsteinsson, Steven Ferris,[...]. N Engl J Med 2014
4
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
4
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
Heiko Braak, Dietmar R Thal, Estifanos Ghebremedhin, Kelly Del Tredici. J Neuropathol Exp Neurol 2011
Heiko Braak, Dietmar R Thal, Estifanos Ghebremedhin, Kelly Del Tredici. J Neuropathol Exp Neurol 2011
4
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Ganesh M Shankar, Shaomin Li, Tapan H Mehta, Amaya Garcia-Munoz, Nina E Shepardson, Imelda Smith, Francesca M Brett, Michael A Farrell, Michael J Rowan, Cynthia A Lemere,[...]. Nat Med 2008
Ganesh M Shankar, Shaomin Li, Tapan H Mehta, Amaya Garcia-Munoz, Nina E Shepardson, Imelda Smith, Francesca M Brett, Michael A Farrell, Michael J Rowan, Cynthia A Lemere,[...]. Nat Med 2008
4
Alzheimer's disease: Targeting the Cholinergic System.
Talita H Ferreira-Vieira, Isabella M Guimaraes, Flavia R Silva, Fabiola M Ribeiro. Curr Neuropharmacol 2016
Talita H Ferreira-Vieira, Isabella M Guimaraes, Flavia R Silva, Fabiola M Ribeiro. Curr Neuropharmacol 2016
4
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois, Harald Hampel, Howard H Feldman, Philip Scheltens, Paul Aisen, Sandrine Andrieu, Hovagim Bakardjian, Habib Benali, Lars Bertram, Kaj Blennow,[...]. Alzheimers Dement 2016
Bruno Dubois, Harald Hampel, Howard H Feldman, Philip Scheltens, Paul Aisen, Sandrine Andrieu, Hovagim Bakardjian, Habib Benali, Lars Bertram, Kaj Blennow,[...]. Alzheimers Dement 2016
4
Tau-targeting therapies for Alzheimer disease.
Erin E Congdon, Einar M Sigurdsson. Nat Rev Neurol 2018
Erin E Congdon, Einar M Sigurdsson. Nat Rev Neurol 2018
4
The complexity of tau in Alzheimer's disease.
Nima N Naseri, Hong Wang, Jennifer Guo, Manu Sharma, Wenjie Luo. Neurosci Lett 2019
Nima N Naseri, Hong Wang, Jennifer Guo, Manu Sharma, Wenjie Luo. Neurosci Lett 2019
4
Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses.
Xu-Qiao Chen, William C Mobley. Front Neurosci 2019
Xu-Qiao Chen, William C Mobley. Front Neurosci 2019
4
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.
Jeffrey L Cummings, Gary Tong, Clive Ballard. J Alzheimers Dis 2019
Jeffrey L Cummings, Gary Tong, Clive Ballard. J Alzheimers Dis 2019
3
Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.
Bayani Uttara, Ajay V Singh, Paolo Zamboni, R T Mahajan. Curr Neuropharmacol 2009
Bayani Uttara, Ajay V Singh, Paolo Zamboni, R T Mahajan. Curr Neuropharmacol 2009
3
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Rachelle S Doody, Ronald G Thomas, Martin Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul S Aisen,[...]. N Engl J Med 2014
Rachelle S Doody, Ronald G Thomas, Martin Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul S Aisen,[...]. N Engl J Med 2014
3
Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
Feng Jin, Qi-Hai Gong, Ya-Sha Xu, Li-Na Wang, Hai Jin, Fei Li, Li-Sheng Li, Yue-Ming Ma, Jing-Shan Shi. Int J Neuropsychopharmacol 2014
Feng Jin, Qi-Hai Gong, Ya-Sha Xu, Li-Na Wang, Hai Jin, Fei Li, Li-Sheng Li, Yue-Ming Ma, Jing-Shan Shi. Int J Neuropsychopharmacol 2014
3
The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
Jianping Jia, Cuibai Wei, Shuoqi Chen, Fangyu Li, Yi Tang, Wei Qin, Lina Zhao, Hongmei Jin, Hui Xu, Fen Wang,[...]. Alzheimers Dement 2018
Jianping Jia, Cuibai Wei, Shuoqi Chen, Fangyu Li, Yi Tang, Wei Qin, Lina Zhao, Hongmei Jin, Hui Xu, Fen Wang,[...]. Alzheimers Dement 2018
3
Cognitive symptoms of Alzheimer's disease: clinical management and prevention.
Elizabeth Joe, John M Ringman. BMJ 2019
Elizabeth Joe, John M Ringman. BMJ 2019
3
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease.
Yunying Yang, Zhentao Zhang. Front Aging Neurosci 2020
Yunying Yang, Zhentao Zhang. Front Aging Neurosci 2020
16
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
Heiko Braak, Irina Alafuzoff, Thomas Arzberger, Hans Kretzschmar, Kelly Del Tredici. Acta Neuropathol 2006
Heiko Braak, Irina Alafuzoff, Thomas Arzberger, Hans Kretzschmar, Kelly Del Tredici. Acta Neuropathol 2006
3
Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy.
Verica Vasic, Kathrin Barth, Mirko H H Schmidt. Int J Mol Sci 2019
Verica Vasic, Kathrin Barth, Mirko H H Schmidt. Int J Mol Sci 2019
7
Microglia-Mediated Synapse Loss in Alzheimer's Disease.
Lawrence Rajendran, Rosa C Paolicelli. J Neurosci 2018
Lawrence Rajendran, Rosa C Paolicelli. J Neurosci 2018
3
3
BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer's Disease Pathology.
Gerald Koelsch. Molecules 2017
Gerald Koelsch. Molecules 2017
4
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update).
Uku Raudvere, Liis Kolberg, Ivan Kuzmin, Tambet Arak, Priit Adler, Hedi Peterson, Jaak Vilo. Nucleic Acids Res 2019
Uku Raudvere, Liis Kolberg, Ivan Kuzmin, Tambet Arak, Priit Adler, Hedi Peterson, Jaak Vilo. Nucleic Acids Res 2019
3
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.